Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2247 ARTÍCULOS , VIENDO DEL 991 AL 1005

Editorial: On the 2024 Alzheimer's Association Criteria: Still Not Ready for Clinical Use

Zhou RZ, Wimo A, Winblad B.

J Prev Alzheimers Dis. 2024;11(4):895-896. doi: 10.14283/jpad.2024.141.

Effectiveness of Resistance Exercise on Cognitive Function in Animal Models of Alzheimer Disease: A Systematic Review and Meta-Analysis

de Andrade Santos FO, Passos AA, Arida RM, Teixeira-Machado L.

J Prev Alzheimers Dis. 2024;11(4):998-1012. doi: 10.14283/jpad.2024.75.

BODIPY in Alzheimer's disease diagnostics: A review

Abramchuk D, Voskresenskaya A, Kuzmichev I, Erofeev A, Gorelkin P, Abakumov M, Beloglazkina E, Krasnovskaya O.

Eur J Med Chem. 2024 Oct 5;276:116682. doi: 10.1016/j.ejmech.2024.116682. Epub 2024 Jul 20.

A Framework for Best Practices and Readiness in the Advent of Anti-Amyloid Therapy for Early Alzheimer's Disease in Asia

Lee JH, Jia J, Ji Y, Kandiah N, Kim S, Mok V, Pai MC, Senanarong V, Suh CH, Chen C.

J Alzheimers Dis. 2024;101(1):1-12. doi: 10.3233/JAD-240684.

Diagnosis and therapy of Alzheimer's disease: Light-driven heterogeneous redox processes

Chen W, Li J, Guo J, Li L, Wu H.

Adv Colloid Interface Sci. 2024 Oct;332:103253. doi: 10.1016/j.cis.2024.103253. Epub 2024 Jul 23.

Primary lateral sclerosis associated with PSEN1 Pro284Leu variant in a Colombian family: Clinical and neuropathological features

Acosta-Uribe J, Villegas-Lanau A, Vallejo D, Ramírez-Aguilar L, Solano JM, Mejía-Cupajita B, Aguillón D, Moreno S, Méndez LG, Baena A, Madrigal L, Bocanegra Y, Quiroz YT, García GP, Vasquez D, Arbeláez A, Lopera F, Beach TG, Kosik KS, White CL 3rd, Giraldo-Chica M.

Alzheimers Dement. 2024 Sep;20(9):6384-6394. doi: 10.1002/alz.14133. Epub 2024 Jul 27.

Nanozymes in Alzheimer's disease diagnostics and therapy

Li L, Zhang W, Cao H, Fang L, Wang W, Li C, He Q, Jiao J, Zheng R.

Biomater Sci. 2024 Sep 10;12(18):4519-4545. doi: 10.1039/d4bm00586d.

Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood-Brain Barrier Crossing Ability

Song Q, Li J, Li T, Li HW.

Adv Sci (Weinh). 2024 Oct;11(38):e2403473. doi: 10.1002/advs.202403473. Epub 2024 Aug 5.

The ADNI PET Core at 20

Jagust WJ, Koeppe RA, Rabinovici GD, Villemagne VL, Harrison TM, Landau SM; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Oct;20(10):7340-7349. doi: 10.1002/alz.14165. Epub 2024 Aug 6.

Evaluation of a novel PET tracer [(18)F]-Florbetazine for Alzheimer's disease diagnosis and β-amyloid deposition quantification

Wu M, Ren C, Mao C, Dong L, Li B, Yang X, Huang Z, Zhang H, Li Y, Yan M, Ge Q, Wu R, Feng F, Cui M, Gao J, Huo L.

Neuroimage. 2024 Sep;298:120779. doi: 10.1016/j.neuroimage.2024.120779. Epub 2024 Aug 8.

Cerebral glucose metabolism in Alzheimer's disease

Salmon E, Collette F, Bastin C.

Cortex. 2024 Oct;179:50-61. doi: 10.1016/j.cortex.2024.07.004. Epub 2024 Aug 3.

The evolving paradigm of Alzheimer's disease diagnosis

The Lancet Neurology.

Lancet Neurol. 2024 Sep;23(9):845. doi: 10.1016/S1474-4422(24)00329-6.

Cancer research provides a model for advancing clinical trials in dementia in the era of disease-modifying Alzheimer's-type dementia therapies

Jicha GA, Tucker TC, Arnold SM, Nelson PT.

Alzheimers Res Ther. 2024 Aug 21;16(1):184. doi: 10.1186/s13195-024-01532-6.

Value proposition of retinal imaging in Alzheimer's disease screening: A review of eight evolving trends

Chan VTT, Ran AR, Wagner SK, Hui HYH, Hu X, Ko H, Fekrat S, Wang Y, Lee CS, Young AL, Tham CC, Tham YC, Keane PA, Milea D, Chen C, Wong TY, Mok VCT, Cheung CY.

Prog Retin Eye Res. 2024 Nov;103:101290. doi: 10.1016/j.preteyeres.2024.101290. Epub 2024 Aug 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias